Enveda at ACT 2026

Nov 15–18, 2026 San Antonio, TX ~1.4k attendees Website

Enveda takes part in 3 sessions at ACT 2026 in San Antonio. Its program centres on genetic toxicology across drug development, from an overview of mechanisms and test methods to what regulators expect. It also works through case studies linking testing practice with regulatory strategy.

OrganizationACT 2026 Attendance
Enveda
Boulder, CO
Biotech companies
Biotech discovering medicines from natural-product chemistry with AI; chairs a course on genetic toxicology in drug development.
Talk
Sun Nov 15
1:00pm–1:30pm
Part of Navigating Genetic Toxicology through Drug Development: Interface of Practice, Strategy, and Regulatory Principles (CE7)
Genetic Toxicology in Drug Development: An Overview of Mechanisms, Methods, and Regulatory Expectations (CE7-1)
Genetic toxicology
Talk
Sun Nov 15
4:00pm–4:30pm
Part of Navigating Genetic Toxicology through Drug Development: Interface of Practice, Strategy, and Regulatory Principles (CE7)
Panel Discussion with Case Studies (CE7-Panel)
Genetic toxicology · with Litron Laboratories

Explore the full ACT 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in San Antonio. Leave your work email and we’ll be in touch.

Privacy

Download the full ACT 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Enveda

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American College of Toxicology (ACT). Organization details are derived from ACT’s published program, exhibitor floor plan and supporter list, and each organization’s own website. Submit a correction